Twist Bioscience Corporation
TWST
$25.31
-$0.30-1.17%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 3.52% | 4.60% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.52% | 4.60% | |||
| Cost of Revenue | -4.29% | 1.94% | |||
| Gross Profit | 11.45% | 7.44% | |||
| SG&A Expenses | -0.47% | 13.34% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.09% | 8.91% | |||
| Operating Income | 27.53% | -19.96% | |||
| Income Before Tax | 152.57% | -24.31% | |||
| Income Tax Expenses | 9.14% | 80.41% | |||
| Earnings from Continuing Operations | 151.85% | -24.48% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 151.85% | -24.48% | |||
| EBIT | 27.53% | -19.96% | |||
| EBITDA | 31.58% | -24.38% | |||
| EPS Basic | 151.55% | -23.46% | |||
| Normalized Basic EPS | 28.21% | -23.29% | |||
| EPS Diluted | 150.05% | -23.46% | |||
| Normalized Diluted EPS | 29.60% | -23.29% | |||
| Average Basic Shares Outstanding | 0.58% | 0.82% | |||
| Average Diluted Shares Outstanding | 2.54% | 0.82% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||